These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32554063)

  • 21. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharma 4.0: analysis on core competence and digital levelling implementation in pharmaceutical industry in Indonesia.
    Nurlaela Arief N; Gustomo A; Rahman Roestan M; Putri ANA; Islamiaty M
    Heliyon; 2022 Aug; 8(8):e10347. PubMed ID: 36082329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virtual pharmaceutical companies: collaborating flexibly in pharmaceutical development.
    Forster SP; Stegmaier J; Spycher R; Seeger S
    Drug Discov Today; 2014 Mar; 19(3):348-55. PubMed ID: 24291787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanobiotech in big pharma: a business perspective.
    Würmseher M; Firmin L
    Nanomedicine (Lond); 2017 Mar; 12(5):535-543. PubMed ID: 28178881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrating Artificial and Human Intelligence: A Partnership for Responsible Innovation in Biomedical Engineering and Medicine.
    Dzobo K; Adotey S; Thomford NE; Dzobo W
    OMICS; 2020 May; 24(5):247-263. PubMed ID: 31313972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 10 years after implementation of TRIPS obligations in India.
    Pawar MD
    Pharm Pat Anal; 2015; 4(3):147-59. PubMed ID: 26030078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Significance of Alliance Networks in Research and Development of Digital Health Products for Diabetes: Observational Study.
    Kikuchi S; Kodama K; Sengoku S
    JMIR Diabetes; 2021 Oct; 6(4):e32446. PubMed ID: 34673525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Art of Virtualizing Pharma R&D.
    Schuhmacher A; Gassmann O; Kuss M; Hinder M
    Drug Discov Today; 2019 Nov; 24(11):2105-2107. PubMed ID: 31323393
    [No Abstract]   [Full Text] [Related]  

  • 29. The endless frontier? The recent increase of R&D productivity in pharmaceuticals.
    Pammolli F; Righetto L; Abrignani S; Pani L; Pelicci PG; Rabosio E
    J Transl Med; 2020 Apr; 18(1):162. PubMed ID: 32272953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomonitoring and Digital Data Technology as an Opportunity for Enhancing Animal Study Translation.
    Defensor EB; Lim MA; Schaevitz LR
    ILAR J; 2021 Dec; 62(1-2):223-231. PubMed ID: 34097730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Artificial Intelligence Approach to Proactively Inspire Drug Discovery with Recommendations.
    Rohall SL; Auch L; Gable J; Gora J; Jansen J; Lu Y; Martin E; Pancost-Heidebrecht M; Shirley B; Stiefl N; Lindvall M
    J Med Chem; 2020 Aug; 63(16):8824-8834. PubMed ID: 32101427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medications development for substance-use disorders: contextual influences (dis)incentivizing pharmaceutical-industry positioning.
    Janero DR
    Expert Opin Drug Discov; 2014 Nov; 9(11):1265-79. PubMed ID: 25162124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of Artificial Intelligence in Pharmaceutical and Biomedical Studies.
    Thakur A; Mishra AP; Panda B; Rodríguez DCS; Gaurav I; Majhi B
    Curr Pharm Des; 2020; 26(29):3569-3578. PubMed ID: 32410553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Economic Impact of Artificial Intelligence in Health Care: Systematic Review.
    Wolff J; Pauling J; Keck A; Baumbach J
    J Med Internet Res; 2020 Feb; 22(2):e16866. PubMed ID: 32130134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dominant logic of Big Tech in healthcare and pharma.
    Schuhmacher A; Haefner N; Honsberg K; Goldhahn J; Gassmann O
    Drug Discov Today; 2023 Feb; 28(2):103457. PubMed ID: 36427777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.
    Fernald KD; Pennings HP; van den Bosch JF; Commandeur HR; Claassen E
    PLoS One; 2017; 12(2):e0172488. PubMed ID: 28231332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artificial intelligence in dentistry: current applications and future perspectives.
    Chen YW; Stanley K; Att W
    Quintessence Int; 2020; 51(3):248-257. PubMed ID: 32020135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.
    D'Hooghe T
    Hum Reprod; 2017 Aug; 32(8):1549-1555. PubMed ID: 28854594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland.
    Heiskanen K; Ahonen R; Kanerva R; Karttunen P; Timonen J
    PLoS One; 2017; 12(6):e0179479. PubMed ID: 28658307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an artificial intelligence-based assessment model for prediction of embryo viability using static images captured by optical light microscopy during IVF.
    VerMilyea M; Hall JMM; Diakiw SM; Johnston A; Nguyen T; Perugini D; Miller A; Picou A; Murphy AP; Perugini M
    Hum Reprod; 2020 Apr; 35(4):770-784. PubMed ID: 32240301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.